{"id":2195,"date":"2021-09-08T09:08:07","date_gmt":"2021-09-08T09:08:07","guid":{"rendered":"https:\/\/www.natcopharma.ca\/?p=2195"},"modified":"2021-09-10T17:20:04","modified_gmt":"2021-09-10T17:20:04","slug":"launch-of-lenalidomide","status":"publish","type":"post","link":"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/","title":{"rendered":"Natco Pharma (Canada) Inc. announces the launch of <sup>Pr<\/sup>NAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid<sup>\u00ae<\/sup>"},"content":{"rendered":"First Press Releases<\/p>\n<p>Lorem Ipsum is simply dummy text of the printing and typesetting industry.<\/p>\n<p>Lorem Ipsum has been the industry&rsquo;s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.","protected":false},"excerpt":{"rendered":"<p>Lorem Ipsum is simply dummy text of the printing and typesetting industry.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[73],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae - Natco Pharma (Canada) Inc.<\/title>\n<meta name=\"robots\" content=\"noindex, nofollow\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:en]Press Releases[:fr]Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae[:] - Natco Pharma (Canada) Inc.\" \/>\n<meta property=\"og:description\" content=\"[:en]Lorem Ipsum is simply dummy text of the printing and typesetting industry. [:fr]Lorem Ipsum is simply dummy text of the printing and typesetting industry.[:]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/\" \/>\n<meta property=\"og:site_name\" content=\"Natco Pharma (Canada) Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T09:08:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-10T17:20:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"natcopharma-wpdmn\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.natcopharma.ca\/#website\",\"url\":\"https:\/\/www.natcopharma.ca\/\",\"name\":\"Natco Pharma (Canada) Inc.\",\"description\":\"Canada&#039;s High Quality Pharmaceutical Supplier\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.natcopharma.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/#webpage\",\"url\":\"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/\",\"name\":\"[:en]Press Releases[:fr]Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae[:] - Natco Pharma (Canada) Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.natcopharma.ca\/#website\"},\"datePublished\":\"2021-09-08T09:08:07+00:00\",\"dateModified\":\"2021-09-10T17:20:04+00:00\",\"author\":{\"@id\":\"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.natcopharma.ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068\",\"name\":\"natcopharma-wpdmn\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.natcopharma.ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g\",\"caption\":\"natcopharma-wpdmn\"},\"sameAs\":[\"https:\/\/dev7710.marketing-aide.com\"],\"url\":\"https:\/\/www.natcopharma.ca\/fr\/author\/natcopharma-wpdmn\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:en]Press Releases[:fr]Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae[:] - Natco Pharma (Canada) Inc.","robots":{"index":"noindex","follow":"nofollow"},"og_locale":"fr_FR","og_type":"article","og_title":"[:en]Press Releases[:fr]Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae[:] - Natco Pharma (Canada) Inc.","og_description":"[:en]Lorem Ipsum is simply dummy text of the printing and typesetting industry. [:fr]Lorem Ipsum is simply dummy text of the printing and typesetting industry.[:]","og_url":"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/","og_site_name":"Natco Pharma (Canada) Inc.","article_published_time":"2021-09-08T09:08:07+00:00","article_modified_time":"2021-09-10T17:20:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"natcopharma-wpdmn","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.natcopharma.ca\/#website","url":"https:\/\/www.natcopharma.ca\/","name":"Natco Pharma (Canada) Inc.","description":"Canada&#039;s High Quality Pharmaceutical Supplier","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.natcopharma.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/#webpage","url":"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/","name":"[:en]Press Releases[:fr]Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae[:] - Natco Pharma (Canada) Inc.","isPartOf":{"@id":"https:\/\/www.natcopharma.ca\/#website"},"datePublished":"2021-09-08T09:08:07+00:00","dateModified":"2021-09-10T17:20:04+00:00","author":{"@id":"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068"},"breadcrumb":{"@id":"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.natcopharma.ca\/fr\/launch-of-lenalidomide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.natcopharma.ca\/"},{"@type":"ListItem","position":2,"name":"Natco Pharma (Canada) Inc. announces the launch of PrNAT- LENALIDOMIDE Capsules, the first generic alternative to Revlimid\u00ae"}]},{"@type":"Person","@id":"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068","name":"natcopharma-wpdmn","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.natcopharma.ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g","caption":"natcopharma-wpdmn"},"sameAs":["https:\/\/dev7710.marketing-aide.com"],"url":"https:\/\/www.natcopharma.ca\/fr\/author\/natcopharma-wpdmn\/"}]}},"_links":{"self":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts\/2195"}],"collection":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/comments?post=2195"}],"version-history":[{"count":7,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts\/2195\/revisions"}],"predecessor-version":[{"id":2214,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts\/2195\/revisions\/2214"}],"wp:attachment":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/media?parent=2195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/categories?post=2195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/tags?post=2195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}